Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
出版年份 2013 全文链接
标题
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
作者
关键词
Fragile X syndrome, Social withdrawal, Inattention, Hyperactivity, Acamprosate, Brain-derived neurotrophic factor, Brain-derived neurotrophic factor (BDNF), Glutamate, Metabotropic type 5 glutamate receptor (mGluR5), Neurodevelopment, Gamma-aminobutyric acid (GABA), <em class=EmphasisTypeItalic >N</em>-methyl-<span class=EmphasisTypeSmallCaps >d
出版物
PSYCHOPHARMACOLOGY
Volume 228, Issue 1, Pages 75-84
出版商
Springer Nature
发表日期
2013-02-23
DOI
10.1007/s00213-013-3022-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model
- (2012) Inge Heulens et al. BEHAVIOURAL BRAIN RESEARCH
- Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma
- (2012) Thomas A. Lanz et al. BIOMARKERS
- Reduction of BDNF expression inFmr1knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits
- (2012) M. Uutela et al. GENES BRAIN AND BEHAVIOR
- Expressions of Brain-Derived Neurotrophic Factor (BDNF) in Cerebrospinal Fluid and Plasma of Children With Meningitis and Encephalitis/Encephalopathy
- (2012) Shinichiro Morichi et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome
- (2012) Hongen Wei et al. PLoS One
- Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test
- (2012) Agnieszka Pałucha-Poniewiera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
- (2011) Jennifer C. Darnell et al. CELL
- The GABAA Receptor Agonist THIP Ameliorates Specific Behavioral Deficits in the Mouse Model of Fragile X Syndrome
- (2011) Jose Luis Olmos-Serrano et al. DEVELOPMENTAL NEUROSCIENCE
- An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder
- (2011) Craig A. Erickson et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Downregulation of GABAA β Subunits is Transcriptionally Controlled by Fmr1p
- (2011) Andrew Hong et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Restraint stress and repeated corticotrophin-releasing factor receptor activation in the amygdala both increase amyloid-β precursor protein and amyloid-β peptide but have divergent effects on brain-derived neurotrophic factor and pre-synaptic proteins in the prefrontal cortex of rats
- (2011) B. Ray et al. NEUROSCIENCE
- Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker
- (2011) Balmiki Ray et al. PLoS One
- Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
- (2011) S. Jacquemont et al. Science Translational Medicine
- Blood BDNF concentrations reflect brain-tissue BDNF levels across species
- (2010) Anders B. Klein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome
- (2010) J. L. Olmos-Serrano et al. JOURNAL OF NEUROSCIENCE
- BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse
- (2010) Verna Louhivuori et al. NEUROBIOLOGY OF DISEASE
- Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
- (2010) Heath D Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology
- (2009) Anilkumar Pillai et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
- (2009) E Berry-Kravis et al. JOURNAL OF MEDICAL GENETICS
- Acamprosate: Recent Findings and Future Research Directions
- (2008) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effects of Acamprosate on Neuronal Receptors and Ion Channels Expressed inXenopusOocytes
- (2008) Matthew T. Reilly et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Co-occurring conditions associated withFMR1gene variations: Findings from a national parent survey
- (2008) Donald B. Bailey et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments
- (2008) Darrick T. Balu et al. BRAIN RESEARCH
- The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats
- (2008) Jolanta Kotlinska et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions
- (2008) Yuri A. Blednov et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome
- (2008) Gül Dölen et al. JOURNAL OF PHYSIOLOGY-LONDON
- Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice
- (2008) Femke M.S. de Vrij et al. NEUROBIOLOGY OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started